MapLight Therapeutics, Inc. (MPLT)
7.06
-0.01
(-0.14%)
USD |
NASDAQ |
Nov 13, 10:51
MapLight Therapeutics Free Cash Flow (Quarterly) : -44.89M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -44.89M |
| March 31, 2026 | -51.20M |
| December 31, 2025 | -47.20M |
| September 30, 2025 | -31.82M |
| June 30, 2025 | -34.03M |
| Date | Value |
|---|---|
| March 31, 2025 | -25.55M |
| June 30, 2024 | -17.82M |
| March 31, 2024 | -19.94M |
| March 31, 2023 | -12.06M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Cullinan Therapeutics, Inc. | -43.08M |
| Arrowhead Pharmaceuticals, Inc. | -181.32M |
| Oncolytics Biotech, Inc. | -8.066M |
| Sangamo Therapeutics, Inc. | -19.30M |
| Sarepta Therapeutics, Inc. | 53.83M |